# EDGAR Filing Document

**Accession Number:** 0001027263
**File Stem:** 0001193125-26-133827
**Filing Date:** 2026-3
**Character Count:** 9777
**Document Hash:** bf0c7be35a35a6612a72bdeb8093c513
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-133827.hdr.sgml**: 20260331

**ACCESSION NUMBER**: 0001193125-26-133827

**CONFORMED SUBMISSION TYPE**: 497K

**PUBLIC DOCUMENT COUNT**: 1

**FILED AS OF DATE**: 20260331

**DATE AS OF CHANGE**: 20260331

**EFFECTIVENESS DATE**: 20260331

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** EQ ADVISORS TRUST
- **CENTRAL INDEX KEY:** 0001027263

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** DE
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** 497K
- **SEC ACT:** 1933 Act
- **SEC FILE NUMBER:** 333-17217
- **FILM NUMBER:** 26819369

**BUSINESS ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105
- **BUSINESS PHONE:** 212-554-1234

**MAIL ADDRESS:**
- **STREET 1:** 1345 AVENUE OF THE AMERICAS
- **CITY:** NEW YORK
- **STATE:** NY
- **ZIP:** 10105

**FORMER COMPANY:**
- **FORMER CONFORMED NAME:** 787 TRUST
- **DATE OF NAME CHANGE:** 19961125

## Series and Classes Contracts Data

### EQ/T. Rowe Price Health Sciences Portfolio (Series ID: S000062644)

| Class ID   | Class Name   | Ticker Symbol   |
|:---|:---|:---|
| C000203168 | Class IB     |  |
| C000203169 | Class K      |  |

EQ ADVISORS TRUST<sup>SM</sup>

**EQ/T. Rowe Price Health Sciences Portfolio** 

**SUPPLEMENT DATED MARCH 31, 2026 TO THE SUMMARY PROSPECTUS, PROSPECTUS AND STATEMENT OF ADDITIONAL INFORMATION DATED MAY 1, 2025, AS SUPPLEMENTED** 

This Supplement updates certain information contained in the Summary Prospectus, Prospectus and Statement of Additional Information ("SAI") of EQ Advisors Trust ("Trust") dated May 1, 2025, as supplemented. You should read this Supplement in conjunction with the Summary Prospectus, Prospectus and SAI and retain it for future reference. You may view, print, and download these documents, free of charge, at the Trust's website at <u>https://equitable-funds.com</u>.

**Effective April 1, 2026, the following changes are being made to the Summary Prospectus, Prospectus and SAI:** 

**The section of the Summary Prospectus and Prospectus entitled "EQ/T. Rowe Price Health Sciences Portfolio – WHO MANAGES THE PORTFOLIO — Sub-Adviser: T. Rowe Price Associates, Inc. ("T. Rowe Price" or the "Sub-Adviser")" is amended by deleting the table in its entirety and replacing it with the following:** 

---

| | | |
|:---|:---|:---|
| &nbsp;&nbsp;&nbsp;**Name** | **Title** | **Since** |
| &nbsp;&nbsp;&nbsp;Ziad Bakri, MD, CFA<sup>®</sup>\* | Chairman of Investment Advisory Committee of<br> T. Rowe Price | 2018 |
| &nbsp;&nbsp;&nbsp;Jeffrey Holford | Portfolio Manager | 2026 |

---

\* Effective June 30, 2026, Ziad Bakri will no longer serve as a portfolio manager.

**The section of the Prospectus entitled "Management of the Trust — The Sub-Advisers — T. Rowe Price Associates, Inc." is amended by deleting the second paragraph in its entirety and replacing it with the following:** 

**Ziad Bakri, MD, CFA<sup>®</sup>, and Jeffrey Holford** are jointly and primarily responsible for the investment decisions for the EQ/T. Rowe Price Health Sciences Portfolio. Effective June 30, 2026, Ziad Bakri will no longer serve as a Portfolio Manager of the Portfolio.

**Ziad Bakri, MD, CFA<sup>®</sup>,** is Chairman of the Investment Advisory Committee for the T. Rowe Price Health Sciences Equity Strategy. He joined T. Rowe Price in 2011.

**Jeffrey Holford,** is a Portfolio Manager of T. Rowe Price. Mr. Holford joined T. Rowe Price in 2018. Effective June 30, 2026, Mr. Holford will be primarily responsible for the security selection, research and trading for the Portfolio.

\*\*\*\*\*

**The section of the SAI entitled "Appendix B — EQ Advisors Trust — Portfolio Manager Information — T. Rowe Price Associates, Inc." is amended to include the following information:** 

---

| | | | | | | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|:---|
| **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** | **T. Rowe Price Associates, Inc. ("T. Rowe Price" or "Sub-Adviser")** |
| **Portfolio Manager** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each portfolio manager is the<br>number of other accounts managed by the<br>portfolio manager and the total assets in the<br>accounts managed within each category as of<br>February 28, 2026** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** | **Presented below for each of the categories is the<br>number of accounts and the total assets in the<br>accounts with respect to which the advisory fee is<br>based on the performance of the account** |
| **Portfolio Manager** | **Registered<br>Investment<br>Companies** | **Registered<br>Investment<br>Companies** | **Other Pooled<br>Investment<br>Vehicles** | **Other Pooled<br>Investment<br>Vehicles** | **Other Accounts** | **Other Accounts** | **Registered<br>Investment<br>Companies** | **Registered<br>Investment<br>Companies** | **Other Pooled<br>Investment<br>Vehicles** | **Other Pooled<br>Investment<br>Vehicles** | **Other Accounts** | **Other Accounts** |
| **Portfolio Manager** | **Number<br>of<br>Accounts** | **Total**<br> **Assets** | **Number<br>of<br>Accounts** | **Total<br>Assets** | **Number<br>of<br>Accounts** | **Total**<br> **Assets** | **Number<br>of<br>Accounts** | **Total**<br> **Assets** | **Number<br>of<br>Accounts** | **Total<br>Assets** | **Number<br>of<br>Accounts** | **Total<br>Assets** |
| **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** |
|  Jeffrey Holford | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A | 0 | N/A |

---

------

**Ownership of Shares of the Portfolio as of February 28, 2026** 

---

| | | | | | | | |
|:---|:---|:---|:---|:---|:---|:---|:---|
| **Portfolio Manager** | **None** | **$1-** <br> **$10000** | **$10001-** <br> **$50000** | **$50001-** <br> **$100000** | **$100001-** <br> **$500000** | **$500001-** <br> **$1000000** | **over**<br> **$1,000,000** |
| **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** | **EQ/T. Rowe Price Health Sciences Portfolio** |
|  Jeffrey Holford | X |  |  |  |  |  |  |

---